A detailed history of Virtus Investment Advisers, Inc. transactions in Vericel Corp stock. As of the latest transaction made, Virtus Investment Advisers, Inc. holds 4,760 shares of VCEL stock, worth $268,940. This represents 0.17% of its overall portfolio holdings.

Number of Shares
4,760
Previous 4,760 -0.0%
Holding current value
$268,940
Previous $218,000 7.8%
% of portfolio
0.17%
Previous 0.2%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023

BUY
$29.0 - $38.37 $138,040 - $182,641
4,760 New
4,760 $178,000

Others Institutions Holding VCEL

About Vericel Corp


  • Ticker VCEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,178,000
  • Market Cap $2.67B
  • Description
  • Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...
More about VCEL
Track This Portfolio

Track Virtus Investment Advisers, Inc. Portfolio

Follow Virtus Investment Advisers, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtus Investment Advisers, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Virtus Investment Advisers, Inc. with notifications on news.